<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="nl">
	<id>https://informatiestandaarden.test-nictiz.nl/index.php?action=history&amp;feed=atom&amp;title=7phcy%3AV6.12.7_EV.usage</id>
	<title>7phcy:V6.12.7 EV.usage - Bewerkingsoverzicht</title>
	<link rel="self" type="application/atom+xml" href="https://informatiestandaarden.test-nictiz.nl/index.php?action=history&amp;feed=atom&amp;title=7phcy%3AV6.12.7_EV.usage"/>
	<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V6.12.7_EV.usage&amp;action=history"/>
	<updated>2026-04-06T22:59:31Z</updated>
	<subtitle>Bewerkingsoverzicht voor deze pagina op de wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V6.12.7_EV.usage&amp;diff=33837&amp;oldid=prev</id>
		<title>Maarten Ligtvoet: Tekst vervangen - &quot;{{DISPLAYTITLE:.*}}&quot; door &quot;&quot;</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V6.12.7_EV.usage&amp;diff=33837&amp;oldid=prev"/>
		<updated>2020-08-25T13:46:03Z</updated>

		<summary type="html">&lt;p&gt;Tekst vervangen - &amp;quot;{{DISPLAYTITLE:.*}}&amp;quot; door &amp;quot;&amp;quot;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;nl&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Oudere versie&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Versie van 25 aug 2020 13:46&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Regel 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{DISPLAYTITLE:EV.usage|EV.usage}}&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;noinclude&amp;gt;{{DocumentPart|ns=7phcy|title=V6.12.7_HL7v3-domeinspecificatie_Pharmacy}}&amp;lt;/noinclude&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;noinclude&amp;gt;{{DocumentPart|ns=7phcy|title=V6.12.7_HL7v3-domeinspecificatie_Pharmacy}}&amp;lt;/noinclude&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Maarten Ligtvoet</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V6.12.7_EV.usage&amp;diff=30175&amp;oldid=prev</id>
		<title>Maarten Ligtvoet: Tekst vervangen - &quot;{{#customtitle:&quot; door &quot;{{DISPLAYTITLE:&quot;</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V6.12.7_EV.usage&amp;diff=30175&amp;oldid=prev"/>
		<updated>2020-07-20T01:22:38Z</updated>

		<summary type="html">&lt;p&gt;Tekst vervangen - &amp;quot;{{#customtitle:&amp;quot; door &amp;quot;{{DISPLAYTITLE:&amp;quot;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;nl&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Oudere versie&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Versie van 20 jul 2020 01:22&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Regel 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;#customtitle&lt;/del&gt;:EV.usage|EV.usage}}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;DISPLAYTITLE&lt;/ins&gt;:EV.usage|EV.usage}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;noinclude&amp;gt;{{DocumentPart|ns=7phcy|title=V6.12.7_HL7v3-domeinspecificatie_Pharmacy}}&amp;lt;/noinclude&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;noinclude&amp;gt;{{DocumentPart|ns=7phcy|title=V6.12.7_HL7v3-domeinspecificatie_Pharmacy}}&amp;lt;/noinclude&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Maarten Ligtvoet</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V6.12.7_EV.usage&amp;diff=13476&amp;oldid=prev</id>
		<title>Maarten Ligtvoet: Copy of V6.12.3</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V6.12.7_EV.usage&amp;diff=13476&amp;oldid=prev"/>
		<updated>2018-01-15T12:43:59Z</updated>

		<summary type="html">&lt;p&gt;Copy of V6.12.3&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nieuwe pagina&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{#customtitle:EV.usage|EV.usage}}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;noinclude&amp;gt;{{DocumentPart|ns=7phcy|title=V6.12.7_HL7v3-domeinspecificatie_Pharmacy}}&amp;lt;/noinclude&amp;gt;&lt;br /&gt;
===EV.usage===&lt;br /&gt;
&lt;br /&gt;
{| style=&amp;quot;color: black; background-color: #CCC0D9;&amp;quot; width=&amp;quot;84%&amp;quot;&lt;br /&gt;
| colspan=&amp;quot;7&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Element: usage&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: white;&amp;quot; colspan=&amp;quot;7&amp;quot;|&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Pad: signedDataPrescription.prescription&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;width: 12%; background-color: white;&amp;quot;|&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Subelement&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| style=&amp;quot;width: 12%; background-color: white;&amp;quot;|&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Tonen&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| style=&amp;quot;width: 12%; background-color: white;&amp;quot;|&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;DT&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| style=&amp;quot;width: 12%; background-color: white;&amp;quot;|&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;#&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| style=&amp;quot;width: 12%; background-color: white;&amp;quot;|&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;C&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| style=&amp;quot;width: 12%; background-color: white;&amp;quot;|&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;LBA&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| style=&amp;quot;width: 12%; background-color: white;&amp;quot;|&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Omschrijving&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: white;&amp;quot;|&lt;br /&gt;
 &lt;br /&gt;
| style=&amp;quot;background-color: white;&amp;quot;|&lt;br /&gt;
ja&lt;br /&gt;
| style=&amp;quot;background-color: white;&amp;quot;|&lt;br /&gt;
string&lt;br /&gt;
| style=&amp;quot;background-color: white;&amp;quot;|&lt;br /&gt;
1..1&lt;br /&gt;
| style=&amp;quot;background-color: white;&amp;quot;|&lt;br /&gt;
M&lt;br /&gt;
|  style=&amp;quot;background-color: white;&amp;quot;|&lt;br /&gt;
gebruiksomschrijving&lt;br /&gt;
| style=&amp;quot;background-color: white;&amp;quot;|&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|  style=&amp;quot;background-color: white;&amp;quot;|&lt;br /&gt;
|  style=&amp;quot;width: 72%; background-color: white;&amp;quot; colspan=&amp;quot;6&amp;quot;|&lt;br /&gt;
Geen matching met bericht.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
De inhoud van usage moet inhoudelijk overeenkomen met de inhoud van de medicationAdministrationRequest elementen in het bericht. Omdat de vorm in het HL7v3 bericht heel anders is (gecodeerde informatie) vindt er geen matching plaats met het bericht. De zender dient ervoor te zorgen dat de tekstuele weergave in de ondertekende gegevens overeenkomt met het HL7v3 bericht.&lt;br /&gt;
&lt;br /&gt;
Voorbeeld:&lt;br /&gt;
&lt;br /&gt;
&amp;lt;syntaxhighlight lang=&amp;quot;xml&amp;quot;&amp;gt;&lt;br /&gt;
  &amp;lt;usage&amp;gt;eerst 2 weken lang 2x daags 2 tabletten dan aansluitend 2 weken lang 2x daags 1 tablet en 4 weken lang 1x daags 1 tablet&amp;lt;/usage&amp;gt;&lt;br /&gt;
&amp;lt;/syntaxhighlight&amp;gt;&lt;/div&gt;</summary>
		<author><name>Maarten Ligtvoet</name></author>
	</entry>
</feed>